In a revolutionary leap for neonatal healthcare, researchers from the Critical Analytics for Manufacturing ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese firms look to ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies insisted the sensitive genetic data provided to 23andMe by 15 million ...

Canadian biotechnology company Quantum Biopharma has bought an additional $1 million worth of Bitcoin and other ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

China has long pushed for closer economic ties with the region, especially as it feuds with Washington on multiple fronts. Chinese firms see Southeast Asia as a fast-growing market that is home to a ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the South San Francisco-based genetic testing company filed for Chapter 11 bankruptcy protection.

BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech, a nanomedicine startup, has been awarded a $100,000 Stage I SBIR Targeted Technologies (START) grant funded by the Commonwealth and managed by ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore ...